EcoDrugPlus

Ensembl ID : ENSPEMG00000022349
Gene Symbol: -
Cross references: -
131 Possible Orthologues:

Ensembl ID : ENSPEMG00000016049
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSPEMG00000027920
Gene Symbol: -
Cross references: -
228 Possible Orthologues:

Ensembl ID : ENSPEMG00000013353
Gene Symbol: -
Cross references: -
119 Possible Orthologues:

Ensembl ID : ENSPEMG00000008389
Gene Symbol: -
Cross references: -
399 Possible Orthologues:

Ensembl ID : ENSPEMG00000007818
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSPEMG00000026130
Gene Symbol: -
Cross references: -
380 Possible Orthologues:

Ensembl ID : ENSPEMG00000015354
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSPEMG00000006674
Gene Symbol: -
Cross references: -
279 Possible Orthologues:

Ensembl ID : ENSPEMG00000030658
Gene Symbol: -
Cross references: -
99 Possible Orthologues:

Ensembl ID : ENSPEMG00000019831
Gene Symbol: -
Cross references: -
130 Possible Orthologues:

Ensembl ID : ENSPEMG00000008328
Gene Symbol: -
Cross references: -
163 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).